Current pharmaceutical design
Computational Exploration of Flavonoids as HCV NS3/4A Protease Inhibitors: Advancing Antiviral Therapies to Mitigate Liver Cancer Risk.
Eman Mahmoud, Mohd Rehan
Published: 202510.2174/0113816128386884250904063752
Abstract
INTRODUCTION: Hepatitis C virus (HCV) remains a major global health challenge, driving chronic hepatitis C (CHC) progression to severe liver diseases, including hepatocellular carcinoma (HCC). Directacting antivirals (DAAs) have transformed HCV treat…
Preview only. Read the full abstract at the source